Home

Pharmaids Pharmaceuticals Ltd EPS

Image

Pharmaids Pharmaceuticals Ltd

NSE: PHARMAIDSPHARMA

EPS

₹ -4.62

Last updated on: Nov 25, 2025

Key Highlights

  • The Earning per Share of Pharmaids Pharmaceuticals Ltd is ₹ -4.62 as of 25 Nov 25 .
  • The earning per share of Pharmaids Pharmaceuticals Ltd changed from ₹ -0.61 to ₹ -0.7 over 10 quarters. This represents a CAGR of 5.66% .

Historical Earning per Share of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Pharmaids Pharmaceuticals Ltd

Market Cap

173 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

3.3

Day’s High

50.29

Day’s Low

46.5

DTE

0.4

ROE

-31.4

52 Week High

84.97

52 Week Low

42.0

ROCE

-26.2

Market Price of Pharmaids Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Pharmaids Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Nov 202549.31
24 Nov 202550.1
21 Nov 202547.6
20 Nov 202546.66
19 Nov 202549.09
18 Nov 202546.99
17 Nov 202547.82
14 Nov 202544.41
13 Nov 202545.81
12 Nov 202544.91

BlinkX Score for Pharmaids Pharmaceuticals Ltd

Asset Value vs Market Value of Pharmaids Pharmaceuticals Ltd

Market Value

174

Asset Value

Value addition

4.2 X

33

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Pharmaids Pharmaceuticals Ltd173.91
Sun Pharmaceutical Industries Ltd425102
Divis Laboratories Ltd170299
Torrent Pharmaceuticals Ltd126747
Cipla Ltd121735
Dr Reddys Laboratories Ltd103155

Historical Market Cap of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Pharmaids Pharmaceuticals Ltd News Hub

Pharmaids Pharmaceuticals to convene board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 August

Read more

21 Aug 24

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.68 crore in the June 2024 quarter

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.68 crore in the quarter ended June 2024 as ag

Read more

14 Aug 24

Pharmaids Pharmaceuticals schedules board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August

Read more

07 Aug 24

Pharmaids Pharmaceuticals AGM scheduled

Pharmaids Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company will b

Read more

03 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Pharmaids Pharmaceuticals Ltd

What is the EPS of Pharmaids Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Pharmaids Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Pharmaids Pharmaceuticals Ltd EPS calculated?

The EPS of Pharmaids Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Pharmaids Pharmaceuticals Ltd report its EPS?

Pharmaids Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Pharmaids Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Pharmaids Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Pharmaids Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Pharmaids Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions